1 / 24

The Changing Field of Melanoma: Ipilimumab

The Changing Field of Melanoma: Ipilimumab. The Changing Field of Melanoma: BRAF Mutations. The Changing Field of Melanoma: PD-1 and PD-L1 Antibodies. Preferred Regimens for Metastatic Melanoma. Considerations With the New Agents. First-Line Therapy for Patients With BRAF Mutation.

zoe-shaw
Download Presentation

The Changing Field of Melanoma: Ipilimumab

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Changing Field of Melanoma: Ipilimumab

  2. The Changing Field of Melanoma: BRAF Mutations

  3. The Changing Field of Melanoma: PD-1 and PD-L1 Antibodies

  4. Preferred Regimens for Metastatic Melanoma

  5. Considerations With the New Agents

  6. First-Line Therapy for Patients With BRAF Mutation

  7. First-Line Therapy for Patients With BRAF Wild Type

  8. Immune-Related Response Criteria

  9. Investigational PD-1 Inhibitors

  10. Investigational Combination Therapy

  11. Questions to Be Answered About PD-1-Blocking Antibodies

  12. Other Investigational Approaches

  13. Other Investigational Approaches (cont)

  14. Investigational Combination Approaches

  15. Abbreviations

  16. Abbreviations (cont)

  17. References

  18. References (cont)

  19. References (cont)

  20. References (cont)

  21. References (cont)

More Related